Bronchodilator responses in Chinese children from asthma index families and the general population

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 6, 2006, Pages 1257-1263

  Kumar, Rajesh ^a   Wang, Binyan ^a,b   Wang, Xiaobin ^a   Chen, Changzhong ^b   Yang, Jianhua ^b   Fu, Lingling ^a   Xu, Xiping ^c  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

airway responsiveness; Bronchodilator response; Chinese; epidemiologic study; risk factors

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADOLESCENT; AGE DISTRIBUTION; ALLERGIC ASTHMA; ARTICLE; ATOPY; BODY HEIGHT; BODY MASS; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CALCULATION; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILY; FAMILY HISTORY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; PUBERTY; RESPIRATORY TRACT DISEASE; RISK FACTOR; RURAL AREA; SCHOOL CHILD; SEX DIFFERENCE; SYMPTOMATOLOGY;

ADOLESCENT; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHINA; FEMALE; HUMANS; MALE;

EID: 33646936091     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.02.049     Document Type: Article

References (51)

1. Peat J.K., and Li J. Reversing the trend: reducing the prevalence of asthma. J Allergy Clin Immunol 103 (1999) 1-10
2. Becklake M., Crapo R., and and participants of Workshop on Lung Function Testing. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 144 (1991) 1202-1218
3. Chan-Yeung M. Spirometry and tests of bronchial hyperresponsiveness in population studies. Int J Tuberc Lung Dis 4 (2000) 633-638
4. D'Amato M., Vitiani L.R., Petrani G., Ferrigno L., diPetro A., Trezza R., and Matricardi P.M. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes: a population study. Am J Respir Crit Care Med 158 (1998) 1968-1973
5. Joos L., Weir T.D., Connett J.E., Anthonisen N.R., Woods R., Pare P.D., et al. Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax 58 (2003) 703-707
6. Litonjua A.A., Silverman E.K., Tantisira K.G., Sparrow D., Sylvia J.S., and Weiss S.T. Beta 2-adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men. Chest 126 (2004) 66-74
7. Kim S.H., Oh S.Y., Oh H.B., Kim Y.K., Cho S.H., Kim Y.Y., et al. Association of beta2-adrenoreceptor polymorphisms with nocturnal cough among atopic subjects but not with atopy and nonspecific bronchial hyperresponsiveness. J Allergy Clin Immunol 109 (2002) 630-635
8. Emala C.W., McQuitty C.K., Eleff S.M., Hopkins-Price P., Lawyer C., Hoh J., et al. Asthma, allergy, and airway hyperresponsiveness are not linked to the beta(2)-adrenoceptor gene. Chest 121 (2002) 722-731
9. Niu T., Rogus J.J., Chen C., Wang B., Yang J., Fang Z., et al. Familial aggregation of bronchodilator response: a community-based study. Am J Respir Crit Care Med 162 (2000) 1833-1837 Erratum in: Am J Respir Crit Care Med 2002;166:774
10. Ouksel H., Meslier N., Badatcheff-Coat A., and Racineux J.L. Influence of predicted FEV1 on bronchodilator response in asthmatic patients. Respiration 70 (2003) 54-59
11. Xu X., Yang J., Chen C., Wang B., Zhang X., Jin Y., et al. Familial aggregation of pulmonary function in a rural Chinese community. Am J Respir Crit Care Med 160 (1999) 1928-1933
12. Rasmussen F., Taylor D.R., Flannery E.M., Cowan J.O., Greene J.M., Herbison J.P., et al. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 165 (2002) 1480-1488
13. Joos G.F. Bronchial hyperresponsiveness: too complex to be useful?. Curr Opin Pharmacol 3 (2003) 233-238
14. Harold F.M. From morphogenes to morphogenesis. Microbiology 141 (1995) 2765-2778
15. Shore S.A. Modeling airway remodeling: the winner by a nose?. Am J Respir Crit Care Med 168 (2003) 910-911
16. Kerstjens H.A., Brand P.L., Quanjer P.H., van der Bruggen-Bogaarts B.A., Koeter G.H., and Postma D.S. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airway disease. Dutch CNSLD Study Group. Thorax 48 (1993) 722-729
17. Crapo R.O. Pulmonary-function testing. N Engl J Med 331 (1994) 25-30
18. Xu X., Niu T., Christiani D.C., Weiss S.T., Chen C., Zhou Y., et al. Occupational and environmental risk factors for asthma in rural communities in China. Int J Occup Environ Health 2 (1996) 172-176
19. Barr R.G., Somers S.C., Speizer F.E., and Camargo Jr. C.A. National Asthma Education and Prevention Program (NAEPP). Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 162 (2002) 1761-1768
20. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74 (1979) 829-836
21. Rodriguez RN, Strokes ME. Recent enhancements and new directions in SAS/STAT Software, part II: nonparametric modeling procedure. In: Proceedings of the 23rd SAS Users Group International Conference. 1998. p. 1262-70.
22. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
23. Oswald H., Phelan P.D., Lanigan A., Hibbert M., Carlin J.B., Bowes G., et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 23 (1997) 14-20
24. Phelan P.D., Robertson C.F., and Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 109 (2002) 189-194
25. Sears M.R., Greene J.M., Willan A.R., Wiecek E.M., Taylor D.R., Flannery E.M., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349 (2003) 1414-1422
26. Rijcken B., Schouten J.P., Weiss S.T., Speizer F.E., and van der Lende R. The association of airways responsiveness to respiratory symptom prevalence and to pulmonary function in a random population sample. Bull Eur Physiopathol Respir 23 (1987) 391-394
27. Nelson H.S. Beta-adrenergic bronchodilators. N Engl J Med 333 (1995) 499-506
28. Wang X., Dockery D.W., Wypij D., Gold D.R., Speizer F.E., Ware J.H., et al. Pulmonary function growth velocity in children 6 to 18 years of age. Am Rev Respir Dis 148 (1993) 1502-1508
29. McKay R.T., and Lockey J.E. Pulmonary function testing: guidelines for medical surveillance and epidemiological studies. Occup Med 6 (1991) 43-57
30. Deerojanawong J., and Prapphal N. Predictors of bronchodilator responsiveness in infants with wheezing associated respiratory tract infection. J Med Assoc Thai 77 (1994) 351-356
31. Israel E., Chinchilli V.M., Ford J.G., Boushey H.A., Cherniack R., Craig T.J., et al. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364 (2004) 1505-1512
32. Lima J.J., Mohamed M.H., Self T.H., Eberle L.V., and Johnson J.A. Importance of beta(2)adrenergic receptor genotype, gender and race on albuterol-evoked bronchodilation in asthmatics. Pulm Pharmacol Ther 13 (2000) 127-134
33. Burchard E.G., Avila P.C., Nazario S., Casal J., Torres A., Rodriguez-Santana J.R., et al. Genetics of Asthmain Latino Americans (GALA) Study. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjectswith asthma. Am J Respir Crit Care Med 169 (2004) 386-392 Epub November 14, 2003
34. Choudhry S., Ung N., Avila P.C., Nazario S., Casal J., Torres A., et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 171 (2005) 563-570
35. Turner D.J., Landau L.I., and LeSouef P.N. The effect of age on bronchodilator responsiveness. Pediatr Pulmonol 15 (1993) 98-104
36. Kizkin O., Turker G., Hacievliyagil S.S., and Gunen H. Asthma, age, and early reversibility testing. J Asthma 40 (2003) 317-321
37. Connolly M.J., Crowley J.J., Charan N.B., Nielson C.P., and Vestal R.E. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 108 (1995) 401-406
38. Kelly H.W., and Murphy S. Beta-adrenergic agonists for acute, severe asthma. Ann Pharmacother 26 (1992) 81-91
39. Ullah M.I., Newman G.B., and Saunders K.B. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 36 (1981) 523-529
40. Weir D.C., and Sherwood Burge P. Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre. Thorax 46 (1991) 43-45
41. Tan K.S., McFarlane L.C., and Lipworth B.J. Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients. Thorax 52 (1997) 608-611
42. Tan K.S., McFarlane L.C., and Lipworth B.J. Beta2-adrenoceptor regulation and function in female asthmatic patients receiving the oral combined contraceptive pill. Chest 113 (1998) 278-282
43. van Den Toorn L.M., Prins J.B., Overbeek S.E., Hoogsteden H.C., and de Jongste J.C. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 162 (2000) 953-957
44. Castro-Rodriguez J.A., Holberg C.J., Morgan W.J., Wright A.L., and Martinez F.D. Increased incidence of asthmalike symptoms in girls who become overweight or obese during the school years. Am J Respir Crit Care Med 163 (2001) 1344-1349
45. Kradjan W.A., Driesner N.K., Abuan T.H., Emmick G., and Schoene R.B. Effect of age on bronchodilator response. Chest 101 (1992) 1545-1551
46. Rodrigo G., and Rodrigo C. Effect of age on bronchodilator response in acute severe asthma treatment. Chest 112 (1997) 19-23
47. Aguado L.I., Petrovic S.L., and Ojeda S.R. Ovarian beta-adrenergic receptors during the onset of puberty: characterization, distribution, and coupling to steroidogenic responses. Endocrinology 110 (1982) 1124-1132
48. Aguado L.I., and Ojeda S.R. Prepubertal ovarian function is finely regulated by direct adrenergic influences: role of noradrenergic innervation. Endocrinology 114 (1984) 1845-1853
49. Weise M., Eisenhofer G., and Merke D.P. Pubertal and gender-related changes in the sympathoadrenal system in healthy children. J Clin Endocrinol Metab 87 (2002) 5038-5043
50. Gray L., Peat J.K., Belousova E., Xuan W., and Woolcock A.J. Family patterns of asthma, atopy and airway hyperresponsiveness: an epidemiological study. Clin Exp Allergy 30 (2000) 393-399
51. Palmer L.J., Burton P.R., Faux J.A., James A.L., Musk A.W., and Cookson W.O. Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness. Am J Respir Crit Care Med 161 (2000) 1836-1843